Alcohol-Associated Liver Disease: Stages, Testing, Recovery

← Patient Education

Alcohol-associated liver disease is liver damage caused by drinking over time, and it ranges from a buildup of fat in the liver that often reverses, to inflammation, scarring, and cirrhosis. Many people first hear the term after a routine blood test shows abnormal liver enzymes, an ultrasound mentions a fatty liver, or a doctor asks more questions about drinking than they expected. This page is for adults in Arlington, Annandale, and the rest of Northern Virginia, and for the people who care about them, who want to understand what the diagnosis means. It explains the stages, how the liver is checked, what treatment involves, and what tends to improve when drinking stops, based on the American College of Gastroenterology's 2024 clinical guideline on alcohol-associated liver disease.

This article is general education, not medical advice. It cannot tell you how healthy your own liver is. That takes your history, your test results, and a physician who can put them together, without judgment.

What alcohol-associated liver disease is

The liver processes alcohol, and over time heavy drinking injures liver cells. The ACG guideline describes the condition as a spectrum: fat in the liver (steatosis), fat plus inflammation (steatohepatitis), scarring (fibrosis), advanced scarring (cirrhosis), and, for some people with cirrhosis, liver cancer. A separate, sudden form called alcohol-associated hepatitis can appear at any point along the way.

The guideline calls alcohol-associated liver disease the leading cause of liver-related death in the United States. It notes that alcohol contributes to about 48 percent of hospital stays for cirrhosis and more than 40 percent of liver transplant listings in the US. It also reports that cases have risen since 2014, with a sharper rise during the COVID-19 pandemic, and that the largest increases have been in younger adults, women, and some minority groups.

Diagnosis rests on two things, according to the guideline: identifying long-term harmful drinking, through a person's own report or through alcohol blood and urine tests, and ruling out other diseases of the liver.

Why the name changed from "alcoholic"

You may still see the older term "alcoholic liver disease" on old records. The ACG and AASLD now use "alcohol-associated," and the 2023 multisociety statement on liver disease names uses "alcohol-associated" or "alcohol-related." That statement was driven partly by concern about stigmatizing language: 61 percent of the experts surveyed found the word "nonalcoholic" stigmatizing. We use the current terms on this page.

Stages of alcohol-associated liver disease

Each stage carries a different outlook, and that is why finding out which stage someone is in matters so much.

• Alcohol-associated fatty liver (steatosis). Fat builds up in liver cells. The American Association for the Study of Liver Diseases (AASLD) 2019 practice guidance says people at this stage are usually without symptoms, and that alcohol-associated steatosis is reversible when drinking stops.
• Steatohepatitis. Fat plus inflammation and injury to liver cells. This also often causes no symptoms and is usually suspected from blood tests.
• Fibrosis. Scar tissue begins to form. The ACG guideline says the degree of scarring is the strongest predictor of how liver disease will play out over time.
• Cirrhosis. Scarring is widespread and changes how the liver is built and how blood flows through it. Our page on cirrhosis covers this stage from any cause.
• Liver cancer. People with advanced scarring or cirrhosis carry a higher risk of hepatocellular carcinoma, the most common liver cancer.

Not everyone who drinks heavily moves through all of these stages. The ACG guideline estimates that only 10 to 20 percent of people with long-term heavy drinking develop cirrhosis. It also notes that, compared with other liver diseases, people with alcohol-associated liver disease tend to progress faster and are more often diagnosed at an advanced stage, often after a complication has already appeared. That gap between how common early disease is and how late it tends to be found is the main reason to get checked.

Alcohol-associated hepatitis: the urgent form

Alcohol-associated hepatitis is a sudden, serious inflammation of the liver in someone who has been drinking heavily. Its hallmark is new or worsening jaundice, a yellowing of the skin and the whites of the eyes. The ACG guideline says that anyone with heavy alcohol use and new jaundice should raise a high suspicion for alcohol-associated hepatitis because of its short-term risk.

The guideline uses criteria from the National Institute on Alcohol Abuse and Alcoholism to make a probable diagnosis without a liver biopsy: jaundice that began within 60 days of a period of heavy drinking lasting at least 6 months, a bilirubin above 3 mg/dL, a specific pattern of liver enzymes, and no other cause of acute hepatitis. A biopsy is considered when the picture is unclear.

Doctors grade severity with a score called MELD, which combines several blood tests. The guideline defines a MELD above 20 as severe and says severe cases should preferably be managed in the hospital. In its most severe forms, the guideline puts the one-month risk of death at 20 to 50 percent, and it recommends corticosteroid treatment for eligible patients, with the response checked after about a week. Moderate cases still carry a 1-year death rate of 10 to 20 percent in the studies the guideline cites. Across both, staying away from alcohol afterward was linked to better long-term survival.

Jaundice is never something to wait out. New yellowing of the skin or eyes, confusion or unusual sleepiness, vomiting blood or material that looks like coffee grounds, black or tarry stools, or a rapidly swelling belly need same-day medical care. Severe confusion, heavy bleeding, or trouble breathing is an emergency. Call 911. Our page on black stools and upper GI bleeding explains why bleeding from the upper digestive tract is urgent in people with liver disease.

Symptoms of alcohol-associated liver disease

In the early stages, alcohol-associated liver disease usually causes no symptoms at all. The ACG guideline says people with early disease may have fat, inflammation, and early scarring without feeling anything. The AASLD guidance adds that a doctor may sometimes feel an enlarged liver on exam before any other sign appears.

Symptoms tend to show up when disease is advanced. The ACG guideline names the complications that mark decompensated cirrhosis: fluid in the belly (ascites), confusion from toxins the liver can no longer clear (hepatic encephalopathy), bleeding from swollen veins in the esophagus or stomach (varices), and liver cancer. The AASLD guidance lists other signs that can come with advanced disease, including tiredness, belly pain, sleeping by day and staying awake at night, weight loss from shrinking muscles, easy bruising, and yellowing of the eyes. Because most of these are not specific to alcohol, a person who drinks heavily and feels unwell for any of these reasons deserves a look at the liver.

How alcohol-associated liver disease is tested

Testing has two goals: confirm that the liver is affected and that alcohol is the main cause, then measure how much scarring there is.

Blood work. A liver panel is usually the starting point. Alcohol-related injury has a pattern of its own, in which the enzyme AST tends to run higher than ALT. Our guide to elevated liver enzymes explains that pattern and the other causes a physician will rule out, such as viral hepatitis, fatty liver from metabolic causes, and hemochromatosis, which alcohol can make worse.

Questions about drinking. The ACG guideline recommends that alcohol use be asked about at every medical visit, in a nonjudgmental way, using short validated questionnaires such as the three-question AUDIT-C. These questions are routine. They exist because many people with liver disease from alcohol were never asked at earlier visits, and the guideline calls those visits missed opportunities.

Alcohol biomarkers. Some blood, urine, and hair tests detect recent drinking over windows ranging from days to months. The guideline describes them as an add-on to conversation, useful when a person cannot be interviewed or the history is uncertain, and says they add nothing when someone has already described recent drinking.

Measuring scarring without a needle. For people without symptoms, the ACG guideline says noninvasive tests should be used to stage scarring. It names a blood-based score called FIB-4 and a liver stiffness scan called transient elastography as the strongest options for alcohol-associated liver disease. It also notes their limits: active drinking can lower platelets and throw off FIB-4, and active inflammation can make a liver look stiffer than its scarring alone would. A liver biopsy is not required for staging and is reserved for cases where the noninvasive results leave real doubt.

The guideline also says screening people who drink heavily with these tests is cost-effective, and that people with heavy drinking whose tests show liver disease should be counseled on the risk of progression and referred to a liver specialist.

Alcohol-associated liver disease and fatty liver from metabolic causes

Many people have more than one thing going on in the liver. Fatty liver linked to excess weight, diabetes, and high blood pressure, now called MASLD, is common, and our page on fatty liver disease covers it. The 2023 multisociety renaming created a category for the overlap called MetALD: metabolic fatty liver plus alcohol intake in a defined middle range, 140 to 350 grams of alcohol a week for women and 210 to 420 grams a week for men. Above that range, the liver disease is classified as alcohol-associated.

The ACG guideline treats the overlap as a two-way risk:

• Obesity and metabolic syndrome raise the risk of advanced liver disease in people who drink heavily, and the guideline recommends that people with obesity avoid alcohol.
• Diabetes combined with heavy drinking was linked to a sixfold higher risk of liver-related hospitalization, death, and liver cancer in one study it cites.
• Smoking adds to the risk of cirrhosis in people who drink heavily, and the guideline recommends avoiding tobacco in any form.
• For people with hepatitis B or C, the guideline recommends avoiding alcohol altogether. Our guide to chronic hepatitis B and C covers those infections.
• Weight-loss surgery can improve metabolic fatty liver, but the guideline notes that gastric bypass is linked to a higher risk of alcohol use disorder and alcohol-associated hepatitis afterward.

Two more points from the guideline are worth knowing. Women develop liver disease at lower amounts of alcohol than men. And while some older studies suggested a small amount of alcohol might protect against metabolic fatty liver, more recent data show that even moderate drinking can favor liver disease in people with obesity and metabolic syndrome.

How much alcohol is too much for the liver

We do not print a "safe" number on this page, because the evidence does not support one for a person with liver disease. The ACG guideline says that any amount of alcohol has the potential to cause harm, and that the risk of advanced liver disease rises with both how much and how long a person drinks, with large differences from person to person because of genes and other health conditions.

For reference, the guideline uses the US definition of one standard drink as about 14 grams of pure alcohol: 12 ounces of regular beer, 5 ounces of wine, or 1.5 ounces of 80-proof spirits. If you already have liver disease of any kind, the question to bring to your physician is not how much is safe but whether you should drink at all.

Treatment for alcohol-associated liver disease

The ACG guideline describes people with this condition as living with two conditions at once: a liver disease and, often, alcohol use disorder. Treating both is the plan.

Stopping drinking is the core treatment

The guideline calls long-term abstinence the most effective therapy to slow alcohol-associated liver disease and even reverse liver damage, at every stage. The AASLD guidance calls it the single most important factor in survival and recommends that everyone with alcohol-associated liver disease be advised to stop completely, while noting that a harm reduction approach based on a person's own goals may fit some situations.

One safety point before anyone stops. For someone who drinks heavily every day, stopping suddenly can bring on alcohol withdrawal. The ACG guideline says withdrawal usually starts within 6 to 24 hours of the last drink and can progress to seizures and delirium, which can be life-threatening. People with liver disease need extra care, because some withdrawal medicines can worsen liver-related confusion. Talk with a physician before stopping so it can be done safely.

Support and medicines for alcohol use disorder

Help works, and the guideline is direct that it is underused. In one large study of veterans with cirrhosis and alcohol use disorder that it cites, only 14 percent received any treatment for the drinking, and fewer than 1 percent received medicine, even though treatment was linked to fewer complications and better survival.

• Counseling and brief interventions. The guideline recommends brief motivational conversations as part of liver care. Cognitive behavioral therapy, motivational enhancement therapy, and 12-step programs such as Alcoholics Anonymous are other options.
• Medicines. For people whose liver disease is compensated, meaning it has not caused major complications, the guideline lists baclofen, acamprosate, naltrexone, gabapentin, and topiramate as options, each with its own cautions that depend on liver and kidney function. It advises that disulfiram not be used in anyone with liver disease, because the liver processes it and it can injure the liver. Which medicine fits, if any, is a decision for your physician.
• Care that works together. The guideline recommends integrated care that brings liver specialists and addiction specialists together. It cites a randomized study in which abstinence rates were 74 percent in a shared clinic compared with 49 percent with usual care.

If you or someone you love is ready to talk about drinking, SAMHSA's National Helpline at 1-800-662-4357 is free, confidential, and open 24 hours a day, 365 days a year, in English and Spanish. The NIAAA Alcohol Treatment Navigator explains the types of treatment and how to find quality care.

Care for the liver itself

Once cirrhosis is present, the ACG guideline says it is managed the same way as cirrhosis from any other cause. That includes:

• Liver cancer surveillance. An ultrasound, with or without an alpha-fetoprotein blood test, every 6 months for people with cirrhosis.
• Nutrition. Malnutrition is common, and the guideline says every person with alcohol-associated liver disease should have their nutrition assessed. Thiamine, vitamin B12, and zinc deficiencies are common when drinking is recent or ongoing.
• Vaccines. The guideline lists hepatitis A and B, influenza, pneumococcus, shingles, tetanus-diphtheria-pertussis, and COVID-19 vaccination for people with chronic liver disease.
• Transplant evaluation. The guideline says people with complications of alcohol-associated cirrhosis should be referred for liver transplant evaluation, and that selection should not rest on a fixed length of sobriety alone, but on a full assessment by the transplant team, including addiction specialists.

What improves when drinking stops

This is the part of alcohol-associated liver disease that gives people the most reason for hope, and it is supported by both guidelines:

• Fatty liver from alcohol is reversible when drinking stops, according to the AASLD guidance.
• Liver damage can partly reverse with prolonged abstinence, according to the ACG guideline, which also says sustained abstinence is the most effective way to prevent progression at any stage.
• Survival after alcohol-associated hepatitis is better in people who do not return to drinking. One study in the guideline found a meaningful survival advantage over about four and a half years of follow-up.
• Cirrhosis can stabilize. The AASLD guidance notes that alcohol-associated liver disease can improve with abstinence enough to change whether a transplant is needed, and suggests transplant referral for people who have not improved after 3 months without alcohol.

Established cirrhosis does not fully reverse, and the cancer risk that comes with it continues, which is why monitoring continues too. A return to drinking is also not the end of the road. It is a reason to reconnect with care.

Questions to bring about alcohol-associated liver disease

Bring every liver test and imaging report you have, with dates, plus a list of all medicines and supplements. Honest numbers about drinking help your physician read the results correctly, and they stay between you and your care team. Questions worth asking:

• Which stage is my liver at, and how do we know?
• Do I need a FIB-4 score, a liver stiffness scan, or other tests to check for scarring?
• Could anything besides alcohol be contributing, such as metabolic fatty liver, hepatitis, or iron overload?
• Is it safe for me to stop drinking on my own, or should withdrawal be managed medically?
• Would a medicine for alcohol use disorder be safe with my liver?
• Do I need liver cancer surveillance or screening for varices?
• Which vaccines am I missing?

Our page on what to expect at your first gastroenterologist visit covers the rest of the appointment. If alcohol has also caused episodes of severe upper belly pain, our guide to pancreatitis explains that related condition.

Alcohol-associated liver disease care in Northern Virginia with GC of NoVA

Gastroenterology Center of Northern Virginia sees adults across Arlington, Annandale, and the surrounding communities with abnormal liver tests, a fatty liver on imaging, known alcohol-associated liver disease, or cirrhosis. Our five gastroenterologists review your history and results without judgment, look for every factor affecting the liver, assess scarring, and plan monitoring and treatment over time, and can help connect patients with support for alcohol use when they want it. Liver care is a core part of our practice, alongside the evaluation of fatty liver, hepatitis, and abnormal liver tests.

We see patients at our Arlington office at 1715 N George Mason Drive, adjacent to VHC Health, and our Annandale office at 3299 Woodburn Road in the Woodburn Medical complex. To schedule a visit, call Arlington at (703) 522-7476 or Annandale at (703) 560-6106, or learn more at gcofnova.com.

This article is for general education and is not medical advice. Talk with a qualified gastroenterologist about your symptoms, diagnosis, and treatment options.